Clinical Trial Update: Repurposing Mirtazapine in Rett Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating repurposing mirtazapine for Rett syndrome with confirmed MECP2 mutation; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: University of Trieste | Conditions: RETT Syndrome With Proven MECP2 Mutation | Phase 2 | Status: RECRUITING